GlassScriptPhysician profile
Herman A Motz
NPI 1376576405
$1,468.55
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $591 · 2021: $616 · 2022: $78.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $402.02 | 2019-2021 | |
| Avanos Medical | $330.23 | 2019-2022 | |
| Medacta USA, INC. | $194.42 | 2021 | |
| Smith+Nephew, INC. | $180.72 | 2020 | |
| Qt Imaging, INC. | $146.65 | 2021 | |
| Conformis, INC. | $132.32 | 2020 | |
| Horizon Therapeutics Plc | $26.17 | 2022 | |
| Stryker Corporation | $22.52 | 2019 | |
| Boston Scientific Corporation | $20.25 | 2022 | |
| Bioventus LLC | $13.25 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Motz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.